Nucl Med Mol Imaging.
2015 Sep;49(3):237-240. 10.1007/s13139-015-0321-9.
FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment
- Affiliations
-
- 1Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. e.quak@baclesse.unicancer.fr
- 2Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
- 3Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
- KMID: 2052059
- DOI: http://doi.org/10.1007/s13139-015-0321-9
Abstract
- The value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in detecting viable tumours in patients with metastasised nonseminomatous testicular cancer and residual and new masses post chemotherapy remains to be determined. We describe the case of a 41-year-old patient with metastasised nonseminomatous testicular cancer, with both retroperitoneal and extra-retroperitoneal residual masses post chemotherapy, for whom FDG-PET/CT guided major treatment decisions. FDG-PET/CT correctly identified the locations of viable tumour, as was proved by histology, and successfully guided surgery. In conclusion, in selected cases surveillance of patients with nonseminomatous testicular cancer with FDG-PET/CT can guide major treatment decisions when considering surgery for metastatic disease.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Role of Multimodality Imaging in Cardiac Sarcoidosis
- Multimodality and Application Software
- FDG-PET in Multimodality Assessment of Cardiac Myxoma
- Primary Carcinoid Tumor Arising in a Mature Teratoma of the Testis: A Case Report
- Management consideration in nonpulmonary visceral metastatic seminoma of testis
